Suscribirse

Study of Nonoutbreak Giardiasis: Novel Findings and Implications for Research - 24/11/11

Doi : 10.1016/j.amjmed.2011.06.012 
Paul T. Cantey, MD, MPH a, b, , Sharon Roy, MD, MPH c, Brian Lee, MPH, PhD d, Alicia Cronquist, RN, MPH e, Kirk Smith, DVM, MS, PhD f, Jennifer Liang, DVM, MPVM g, Michael J. Beach, PhD c
a Epidemic Intelligence Service, Office of Surveillance, Epidemiology, and Laboratory Services, Centers for Disease Control and Prevention, Atlanta, Ga 
b Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Ga 
c Division of Foodborne, Waterborne, and Environmental Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Ga 
d Minnesota Population Center, University of Minnesota, Minneapolis, Minn 
e Colorado Department of Health and Environment, Denver, Colo 
f Minnesota Department of Health, St. Paul, Minn 
g Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Ga 

Requests for reprints should be addressed to Paul T. Cantey, MD, MPH, Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention, 1600 Clifton Road, MS A-06, Atlanta, GA 30333

Abstract

Background

The burden of nonoutbreak-related Giardia infections in the US is poorly understood, with little information on its impact on people's lives and on unusual manifestations of infection. This study was designed with the objectives of better defining the impact of infection, examining the occurrence of extraintestinal manifestations, and determining risk factors for delayed treatment of infection.

Methods

Foodborne Diseases Active Surveillance Network surveillance was used to identify persons with nonoutbreak-related, laboratory-confirmed Giardia infection. People were enrolled into the Risk Factor arm and the Delayed Enrollment arm. Detailed questionnaires collected information on clinical manifestations, impact on activities of daily living, health care utilization, and treatment.

Results

The study enrolled 290 people. Multivariate predictors of delayed study enrollment, a surrogate for delayed diagnosis of Giardia, included intermittent diarrheal symptoms, delayed time to first health care visit, and income. Decreased ability to participate in one's activities of daily living was reported by 210 (72.4%) participants. Appropriate therapeutic agent for Giardia was received by 237 (81.7%) by the time of study enrollment. Extraintestinal manifestations of Giardia were reported by 72 (33.8%) persons who enrolled in the Risk Factor arm.

Conclusions

The presence of intermittent diarrhea contributes to delayed health-seeking behavior and to delayed diagnosis of Giardia. More study is needed to determine if this symptom can help distinguish Giardia from other causes of infectious diarrhea. The occurrence of extraintestinal manifestations of Giardia infection does not appear to be rare, and merits further study.

El texto completo de este artículo está disponible en PDF.

Keywords : Diarrhea, Extraintestinal manifestations, Giardia, Nonoutbreak


Esquema


 Funding: This study was funded by the Centers for Disease Control and Prevention (CDC) Emerging Infections Program; the US Department of Agriculture Food Safety and Inspection Service; and the Food and Drug Administration Center for Food Safety and Applied Nutrition. The findings and conclusions in this report are those of the authors and do not represent the views of the CDC.
 Conflict of Interests: None.
 Authorship: All authors had access to the data and played a role in writing the manuscript.


© 2011  Elsevier Inc. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 124 - N° 12

P. 1175.e1-1175.e8 - décembre 2011 Regresar al número
Artículo precedente Artículo precedente
  • Endothelial Dysfunction Is Reversible in Helicobacter Pylori-Positive Subjects
  • Arnon Blum, Snait Tamir, Keren Mualem, Rotem Shelly Ben-Shushan, Lital Keinan-Boker, Maya Paritsky
| Artículo siguiente Artículo siguiente
  • Processes of Care and Outcomes for Community-Acquired Pneumonia
  • Jonathan S. Lee, Brian A. Primack, Maria K. Mor, Roslyn A. Stone, D. Scott Obrosky, Donald M. Yealy, Michael J. Fine

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.